Real-world evidence research in metastatic colorectal cancer: raising awareness of the need for patient contributions

Real-world evidence (RWE) research provides information that is essential to improving medical treatment. When it comes to metastatic colorectal cancer (mCRC) – cancer that has spread to other parts of the body – only a few RWE studies have been conducted. RWE studies, such as the ongoing PROMETCO study in patients with mCRC, differ from clinical trials in that they include a wider range of people with fewer restrictions on type of treatments received. They can also place more attention to the patients’ own opinions. By joining RWE studies, patients are likely to become more interested in their disease and take a more active role in their treatment. In the end, this can help to improve their quality of life and possibly improve the outcomes of their treatment. Doctors need to work in partnership with patients to increase participation in RWE studies.

Read this manuscript about Real World Evidence here >>

Authors: Barbara Moss, Edward A Goodall, Zorana Maravic, Francisca Marti, Mark Moss, Stephen Rowley, Cyril Sarrauste & Pete Wheatstone